Yunliang Chen

823 total citations
19 papers, 676 citations indexed

About

Yunliang Chen is a scholar working on Molecular Biology, Pharmacology and Cell Biology. According to data from OpenAlex, Yunliang Chen has authored 19 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Cell Biology. Recurrent topics in Yunliang Chen's work include Connective Tissue Growth Factor Research (5 papers), Pharmacological Effects of Natural Compounds (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Yunliang Chen is often cited by papers focused on Connective Tissue Growth Factor Research (5 papers), Pharmacological Effects of Natural Compounds (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Yunliang Chen collaborates with scholars based in United Kingdom, China and Canada. Yunliang Chen's co-authors include Shiwen Xu, Carol M. Black, Andrew Leask, David Abraham, Karen M. Lyons, Jeremy D. Pearson, David E. Carter, Laura Kennedy, Mark Eastwood and Daphne Pala and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Yunliang Chen

17 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunliang Chen United Kingdom 12 434 109 73 72 66 19 676
Laurence Vindevoghel United States 8 536 1.2× 76 0.7× 40 0.5× 44 0.6× 42 0.6× 10 775
Jasmine G. Waters United Kingdom 8 593 1.4× 44 0.4× 49 0.7× 98 1.4× 22 0.3× 11 1.2k
Julien Laboureau France 8 202 0.5× 111 1.0× 57 0.8× 68 0.9× 24 0.4× 11 421
Donna Wang United States 9 335 0.8× 36 0.3× 59 0.8× 117 1.6× 34 0.5× 14 677
Arja Jukkola‐Vuorinen Finland 15 196 0.5× 43 0.4× 38 0.5× 71 1.0× 25 0.4× 40 687
Julian Nüchel Germany 12 304 0.7× 40 0.4× 28 0.4× 103 1.4× 85 1.3× 14 634
Ping‐Ping Kuang United States 17 428 1.0× 58 0.5× 33 0.5× 84 1.2× 28 0.4× 27 898
Charlotte Tacheau France 10 205 0.5× 39 0.4× 77 1.1× 41 0.6× 30 0.5× 11 387
Wendong Bai China 14 528 1.2× 28 0.3× 76 1.0× 23 0.3× 61 0.9× 21 711
Ramin Zargham Canada 11 160 0.4× 25 0.2× 86 1.2× 76 1.1× 43 0.7× 14 425

Countries citing papers authored by Yunliang Chen

Since Specialization
Citations

This map shows the geographic impact of Yunliang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunliang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunliang Chen more than expected).

Fields of papers citing papers by Yunliang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunliang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunliang Chen. The network helps show where Yunliang Chen may publish in the future.

Co-authorship network of co-authors of Yunliang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yunliang Chen. A scholar is included among the top collaborators of Yunliang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunliang Chen. Yunliang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Yunliang, Zengfeng Pan, Shunsheng Cao, et al.. (2025). Glycyrrhizic acid reduces neutrophil extracellular trap formation to ameliorate colitis-associated colorectal cancer by inhibiting peptidylarginine deiminase 4. Journal of Ethnopharmacology. 341. 119337–119337. 4 indexed citations
2.
Xu, Rui‐Hua, Bo Xu, Shunsheng Cao, et al.. (2025). Evaluating the efficacy and safety of emodin, luteolin, and paeonol combination from Dahuang Mudan decoction in ameliorating ulcerative colitis. Journal of Ethnopharmacology. 346. 119692–119692.
3.
Li, Pengcheng, Rui‐Hua Xu, Hongxu Chen, et al.. (2025). The promoting effect of high-fat diet-induced trained immunity on ulcerative colitis and the mechanism of the therapeutic effect of Dahuang Mudan Decoction. Phytomedicine. 143. 156893–156893. 2 indexed citations
4.
Chen, Yunliang, Pengcheng Li, Meng Zhao, et al.. (2024). Liquiritin improves macrophage degradation of engulfed tumour cells by promoting the formation of phagolysosomes via NOX2/gp91phox. Journal of Pharmaceutical Analysis. 15(5). 101093–101093.
5.
6.
Chen, Yunliang & Michael Scully. (2023). The Tumorigenicity of Breast Cancer Cells Is Reduced upon Treatment with Small Extracellular Vesicles Isolated from Heparin Treated Cell Cultures. International Journal of Molecular Sciences. 24(21). 15736–15736. 1 indexed citations
7.
Zhao, Meng, Xueqian Xie, Bo Xu, et al.. (2023). Paeonol alleviates ulcerative colitis in mice by increasing short-chain fatty acids derived from Clostridium butyricum. Phytomedicine. 120. 155056–155056. 22 indexed citations
8.
Pan, Zengfeng, Yunliang Chen, Junjie Liang, et al.. (2022). Huang Qin Decoction inhibits the initiation of experimental colitis associated carcinogenesis by controlling the PAD4 dependent NETs. Phytomedicine. 107. 154454–154454. 24 indexed citations
9.
Chen, Yunliang & Michael Scully. (2022). Tumour-associated Mucin1 correlates with the procoagulant properties of cancer cells of epithelial origin. SHILAP Revista de lepidopterología. 9. 100123–100123. 4 indexed citations
10.
Wu, Kan, et al.. (2014). Capilliposide Isolated from Lysimachia capillipes Hemsl. Induces ROS Generation, Cell Cycle Arrest, and Apoptosis in Human Nonsmall Cell Lung Cancer Cell Lines. Evidence-based Complementary and Alternative Medicine. 2014(1). 497456–497456. 20 indexed citations
12.
Chen, Yunliang, et al.. (2013). Binding and inhibition of drug transport proteins by heparin. Cancer Biology & Therapy. 15(1). 135–145. 12 indexed citations
13.
Denton, Christopher P., Korsa Khan, Rachel K. Hoyles, et al.. (2008). Inducible Lineage-Specific Deletion of TβRII in Fibroblasts Defines a Pivotal Regulatory Role during Adult Skin Wound Healing. Journal of Investigative Dermatology. 129(1). 194–204. 61 indexed citations
14.
Liu, Shangxi, Shiwen Xu, Laura Kennedy, et al.. (2007). FAK Is Required for TGFβ-induced JNK Phosphorylation in Fibroblasts: Implications for Acquisition of a Matrix-remodeling Phenotype. Molecular Biology of the Cell. 18(6). 2169–2178. 112 indexed citations
15.
Xu, Shiwen, Laura Kennedy, Daphne Pala, et al.. (2006). CCN2 Is Necessary for Adhesive Responses to Transforming Growth Factor-β1 in Embryonic Fibroblasts. Journal of Biological Chemistry. 281(16). 10715–10726. 136 indexed citations
16.
Chen, Yu-Jen, Yu-Jen Chen, Kai‐Wen Hsu, Yunliang Chen, & Yunliang Chen. (2006). Acute glucose overload potentiates nitric oxide production in lipopolysaccharide-stimulated macrophages: The role of purinergic receptor activation. Cell Biology International. 30(10). 817–822. 11 indexed citations
17.
Kennedy, Laura, Shangxi Liu, Shiwen Xu, et al.. (2006). CCN2 is necessary for the function of mouse embryonic fibroblasts. Experimental Cell Research. 313(5). 952–964. 78 indexed citations
18.
Chen, Yu-Jen, Yu-Jen Chen, Kai‐Wen Hsu, et al.. (2005). Involvement of protein kinase C in the inhibition of lipopolysaccharide-induced nitric oxide production by thapsigargin in RAW 264.7 macrophages. The International Journal of Biochemistry & Cell Biology. 37(12). 2574–2585. 14 indexed citations
19.
Chen, Yunliang, David Abraham, Shiwen Xu, et al.. (2004). CCN2 (Connective Tissue Growth Factor) Promotes Fibroblast Adhesion to Fibronectin. Molecular Biology of the Cell. 15(12). 5635–5646. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026